Chronopoulos, J.* ; Crespo, M. & Chavakis, T. Central trained immunity in the context of bladder cancer immunotherapy. Cancer Cell 43, 1394-1396 (2025)
Schweizer, L.* et al. Spatial proteo-transcriptomic profiling reveals the molecular landscape of borderline ovarian tumors and their invasive progression. Cancer Cell, DOI: 10.1016/j.ccell.2025.06.004 (2025)
Stahl, D.* et al. CSF1R+ myeloid-monocytic cells drive CAR-T cell resistance in aggressive B cell lymphoma. Cancer Cell, DOI: 10.1016/j.ccell.2025.05.013 (2025)
Wagner, S. et al. Transformer-based biomarker prediction from colorectal cancer histology: A large-scale multicentric study. Cancer Cell 41, 1650-1661.e4 (2023)
Ravi, V.M.* et al. Spatially resolved multi-omics deciphers bidirectional tumor-host interdependence in glioblastoma. Cancer Cell 40, 639-655.e13 (2022)
Salik, B.* et al. Targeting RSPO3-LGR4 signaling for leukemia stem cell eradication in acute myeloid leukemia. Cancer Cell 38, 263-278.e6 (2020)
O'Connor, T. et al. Age-related gliosis promotes central nervous system lymphoma through CCL19-mediated tumor cell retention. Cancer Cell 36, 250-267.e9 (2019)
Huang, J.* et al. Adipocyte p62/SQSTM1 suppresses tumorigenesis through opposite regulations of metabolism in adipose tissue and tumor. Cancer Cell 33, 770-784.e6 (2018)
Boege, Y.* et al. A dual role of caspase-8 in triggering and sensing proliferation-associated DNA damage, a key determinant of liver cancer development. Cancer Cell 32, 342-359.e10 (2017)
Yuan, D.T. et al. Kupffer cell-derived Tnf triggers cholangiocellular tumorigenesis through JNK due to chronic mitochondrial dysfunction and ROS. Cancer Cell 31, 771-789.e6 (2017)
Ebinger, S. et al. Characterization of rare, dormant, and therapy-resistant cells in acute lymphoblastic leukemia. Cancer Cell 30, 849-862 (2016)
Eggert, T.* et al. Distinct functions of senescence-associated immune responses in liver tumor surveillance and tumor progression. Cancer Cell 30, 533-547 (2016)
Endig, J.* et al. Dual role of the adaptive immune system in liver injury and hepatocellular carcinoma development. Cancer Cell 30, 308-323 (2016)
Höckendorf, U.* et al. RIPK3 restricts myeloid leukemogenesis by promoting cell death and differentiation of leukemia initiating cells. Cancer Cell 30, 75-91 (2016)
Townsend, E.C.* et al. The public repository of xenografts enables discovery and randomized phase II-like trials in mice. Cancer Cell 29, 574-586 (2016)
Weber, A.* & Heikenwälder, M. P(URI)fying novel drivers of NASH and HCC: A feedforward loop of IL17A via white adipose tissue. Cancer Cell 30, 15-17 (2016)
Wolf, M.J.* et al. Metabolic activation of intrahepatic CD8+ T cells and NKT cells causes nonalcoholic steatohepatitis and liver cancer via cross-talk with hepatocytes. Cancer Cell 26, 549-564 (2014)
Nagel, D. et al. Pharmacologic inhibition of MALT1 protease by phenothiazines as a therapeutic approach for the treatment of aggressive ABC-DLBCL. Cancer Cell 22, 825-837 (2012)
Wolf, M.J.* et al. Endothelial CCR2 signaling induced by colon carcinoma cells enables extravasation via the JAK2-Stat5 and p38MAPK pathway. Cancer Cell 22, 91-105 (2012)
Bettermann, K.* et al. TAK1 suppresses a NEMO-dependent but NF-κB-independent pathway to liver cancer. Cancer Cell 17, 481-496 (2010)
Müller-Hermelink, N.* et al. TNFR1 signaling and IFN-gamma signaling determine whether T cells induce tumor dormancy or promote multistage carcinogenesis. Cancer Cell 13, 507-518 (2008)
Deshpande, A.J. et al. Acute myeloid leukemia is propagated by a leukemic stem cell with lymphoid characteristics in a mouse model of CALM/AF10-positive leukemia. Cancer Cell 10, 363-374 (2006)
Wei, J.* et al. Embryonic endothelial progenitor cells armed with a suicide gene target hypoxic lung metastasis after intravenous delivery. Cancer Cell 5, 477-488 (2004)
Zhu, P.* et al. Induction of HDAC2 expression upon loss of APC in colorectal tumorigenesis. Cancer Cell 5, 455-463 (2004)